Skip to main content
. Author manuscript; available in PMC: 2010 Nov 4.
Published in final edited form as: Hepatology. 1991 Apr;13(4):619–626.

Fig. 1.

Fig. 1

Percentage of patients who survived more than 60 days who became positive as time passed for the serological or clinical parameters shown. Once a change to positive occurred, this was permanent and contributory to subsequent cumulative scores with the exception of the anti-HBs antibodies. The rise in anti-HBs antibodies in the first 100 days and subsequent decline reflected HBIG administration and later discontinuance.